A structure-based tool to interpret the significance of kinase mutations in clinical next generation sequencing in cancer

Amith Rangarajan, Ilona Sviezhentseva, Emma Gunderson, Yana Pikman, Matthew P. Jacobson, Beth Apsel Winger

Open source

DOI
10.3389/fonc.2025.1599389
Published
2025-08-04
Container
Frontiers in Oncology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2025.1599389,
  title = {A structure-based tool to interpret the significance of kinase mutations in clinical next generation sequencing in cancer},
  author = {Amith Rangarajan and Ilona Sviezhentseva and Emma Gunderson and Yana Pikman and Matthew P. Jacobson and Beth Apsel Winger},
  year = {2025},
  journal = {Frontiers in Oncology},
  doi = {10.3389/fonc.2025.1599389},
  url = {https://doi.org/10.3389/fonc.2025.1599389}
}

RIS

TY  - JOUR
TI  - A structure-based tool to interpret the significance of kinase mutations in clinical next generation sequencing in cancer
AU  - Amith Rangarajan
AU  - Ilona Sviezhentseva
AU  - Emma Gunderson
AU  - Yana Pikman
AU  - Matthew P. Jacobson
AU  - Beth Apsel Winger
PY  - 2025
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2025.1599389
UR  - https://doi.org/10.3389/fonc.2025.1599389
ER  - 

APA

Rangarajan, A., Sviezhentseva, I., Gunderson, E., Pikman, Y., Jacobson, M. P., & Winger, B. A. (2025). A structure-based tool to interpret the significance of kinase mutations in clinical next generation sequencing in cancer. Frontiers in Oncology. https://doi.org/10.3389/fonc.2025.1599389

Source records